Global Chromosomal Abnormality Market Research Report 2016

September 2016 | 116 pages | ID: G1096ABF8E1EN
QYResearch

Abstracts

Notes:

Production, means the output of Chromosomal Abnormality

Revenue, means the sales value of Chromosomal Abnormality

This report studies Chromosomal Abnormality in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Abbott Molecular Inc. (US)
• Life Technologies Corporation (US)
• Affymetrix, Inc. (US)
• PerkinElmer, Inc. (US)
• Bluegnome, ltd. (UK)
• Applied Spectral Imaging (US)
• SciGene Corporation (US)
• BI Biological Industries (Israel)
• ChromTrax (US)
• CytoTest, Inc. (UK)
• Cytognomix, Inc. (Canada)
• Illumina, Inc. (US)
• Inter Medico (Canada)
• Kreatech Diagnostics (The Netherlands)
• Oxford Gene Technology (UK)
• Roche NimbleGen, Inc. (US)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Chromosomal Abnormality in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Chromosomal Abnormality in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Chromosomal Abnormality Market Research Report 2016

1 CHROMOSOMAL ABNORMALITY MARKET OVERVIEW

1.1 Product Overview and Scope of Chromosomal Abnormality
1.2 Chromosomal Abnormality Segment by Type
  1.2.1 Global Production Market Share of Chromosomal Abnormality by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Chromosomal Abnormality Segment by Application
  1.3.1 Chromosomal Abnormality Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Chromosomal Abnormality Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Chromosomal Abnormality (2011-2021)

2 GLOBAL CHROMOSOMAL ABNORMALITY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Chromosomal Abnormality Production and Share by Manufacturers (2015 and 2016)
2.2 Global Chromosomal Abnormality Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Chromosomal Abnormality Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Chromosomal Abnormality Manufacturing Base Distribution, Sales Area and Product Type
2.5 Chromosomal Abnormality Market Competitive Situation and Trends
  2.5.1 Chromosomal Abnormality Market Concentration Rate
  2.5.2 Chromosomal Abnormality Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL CHROMOSOMAL ABNORMALITY PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Chromosomal Abnormality Production and Market Share by Region (2011-2016)
3.2 Global Chromosomal Abnormality Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL CHROMOSOMAL ABNORMALITY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Chromosomal Abnormality Consumption by Regions (2011-2016)
4.2 North America Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Chromosomal Abnormality Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL CHROMOSOMAL ABNORMALITY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Chromosomal Abnormality Production and Market Share by Type (2011-2016)
5.2 Global Chromosomal Abnormality Revenue and Market Share by Type (2011-2016)
5.3 Global Chromosomal Abnormality Price by Type (2011-2016)
5.4 Global Chromosomal Abnormality Production Growth by Type (2011-2016)

6 GLOBAL CHROMOSOMAL ABNORMALITY MARKET ANALYSIS BY APPLICATION

6.1 Global Chromosomal Abnormality Consumption and Market Share by Application (2011-2016)
6.2 Global Chromosomal Abnormality Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL CHROMOSOMAL ABNORMALITY MANUFACTURERS PROFILES/ANALYSIS

7.1 Abbott Molecular Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Chromosomal Abnormality Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Abbott Molecular Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Life Technologies Corporation (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Chromosomal Abnormality Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Life Technologies Corporation (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Affymetrix, Inc. (US)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Chromosomal Abnormality Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Affymetrix, Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 PerkinElmer, Inc. (US)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Chromosomal Abnormality Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 PerkinElmer, Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bluegnome, ltd. (UK)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Chromosomal Abnormality Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bluegnome, ltd. (UK) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Applied Spectral Imaging (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Chromosomal Abnormality Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Applied Spectral Imaging (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 SciGene Corporation (US)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Chromosomal Abnormality Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 SciGene Corporation (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 BI Biological Industries (Israel)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Chromosomal Abnormality Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 BI Biological Industries (Israel) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 ChromTrax (US)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Chromosomal Abnormality Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 ChromTrax (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 CytoTest, Inc. (UK)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Chromosomal Abnormality Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 CytoTest, Inc. (UK) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Cytognomix, Inc. (Canada)
7.12 Illumina, Inc. (US)
7.13 Inter Medico (Canada)
7.14 Kreatech Diagnostics (The Netherlands)
7.15 Oxford Gene Technology (UK)
7.16 Roche NimbleGen, Inc. (US)

8 CHROMOSOMAL ABNORMALITY MANUFACTURING COST ANALYSIS

8.1 Chromosomal Abnormality Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Chromosomal Abnormality

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Chromosomal Abnormality Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CHROMOSOMAL ABNORMALITY MARKET FORECAST (2016-2021)

12.1 Global Chromosomal Abnormality Production, Revenue Forecast (2016-2021)
12.2 Global Chromosomal Abnormality Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Chromosomal Abnormality Production Forecast by Type (2016-2021)
12.4 Global Chromosomal Abnormality Consumption Forecast by Application (2016-2021)
12.5 Chromosomal Abnormality Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chromosomal Abnormality
Figure Global Production Market Share of Chromosomal Abnormality by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Chromosomal Abnormality Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Chromosomal Abnormality Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Chromosomal Abnormality Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Chromosomal Abnormality Production of Key Manufacturers (2015 and 2016)
Table Global Chromosomal Abnormality Production Share by Manufacturers (2015 and 2016)
Figure 2015 Chromosomal Abnormality Production Share by Manufacturers
Figure 2016 Chromosomal Abnormality Production Share by Manufacturers
Table Global Chromosomal Abnormality Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Chromosomal Abnormality Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Chromosomal Abnormality Revenue Share by Manufacturers
Table 2016 Global Chromosomal Abnormality Revenue Share by Manufacturers
Table Global Market Chromosomal Abnormality Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Chromosomal Abnormality Average Price of Key Manufacturers in 2015
Table Manufacturers Chromosomal Abnormality Manufacturing Base Distribution and Sales Area
Table Manufacturers Chromosomal Abnormality Product Type
Figure Chromosomal Abnormality Market Share of Top 3 Manufacturers
Figure Chromosomal Abnormality Market Share of Top 5 Manufacturers
Table Global Chromosomal Abnormality Production by Regions (2011-2016)
Figure Global Chromosomal Abnormality Production and Market Share by Regions (2011-2016)
Figure Global Chromosomal Abnormality Production Market Share by Regions (2011-2016)
Figure 2015 Global Chromosomal Abnormality Production Market Share by Regions
Table Global Chromosomal Abnormality Revenue by Regions (2011-2016)
Table Global Chromosomal Abnormality Revenue Market Share by Regions (2011-2016)
Table 2015 Global Chromosomal Abnormality Revenue Market Share by Regions
Table Global Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table China Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table India Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Chromosomal Abnormality Consumption Market by Regions (2011-2016)
Table Global Chromosomal Abnormality Consumption Market Share by Regions (2011-2016)
Figure Global Chromosomal Abnormality Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Chromosomal Abnormality Consumption Market Share by Regions
Table North America Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table Europe Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table China Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table Japan Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table India Chromosomal Abnormality Production, Consumption, Import & Export (2011-2016)
Table Global Chromosomal Abnormality Production by Type (2011-2016)
Table Global Chromosomal Abnormality Production Share by Type (2011-2016)
Figure Production Market Share of Chromosomal Abnormality by Type (2011-2016)
Figure 2015 Production Market Share of Chromosomal Abnormality by Type
Table Global Chromosomal Abnormality Revenue by Type (2011-2016)
Table Global Chromosomal Abnormality Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Chromosomal Abnormality by Type (2011-2016)
Figure 2015 Revenue Market Share of Chromosomal Abnormality by Type
Table Global Chromosomal Abnormality Price by Type (2011-2016)
Figure Global Chromosomal Abnormality Production Growth by Type (2011-2016)
Table Global Chromosomal Abnormality Consumption by Application (2011-2016)
Table Global Chromosomal Abnormality Consumption Market Share by Application (2011-2016)
Figure Global Chromosomal Abnormality Consumption Market Share by Application in 2015
Table Global Chromosomal Abnormality Consumption Growth Rate by Application (2011-2016)
Figure Global Chromosomal Abnormality Consumption Growth Rate by Application (2011-2016)
Table Abbott Molecular Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Molecular Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Molecular Inc. (US) Chromosomal Abnormality Market Share (2011-2016)
Table Life Technologies Corporation (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Life Technologies Corporation (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure Life Technologies Corporation (US) Chromosomal Abnormality Market Share (2011-2016)
Table Affymetrix, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affymetrix, Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure Affymetrix, Inc. (US) Chromosomal Abnormality Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PerkinElmer, Inc. (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure PerkinElmer, Inc. (US) Chromosomal Abnormality Market Share (2011-2016)
Table Bluegnome, ltd. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluegnome, ltd. (UK) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bluegnome, ltd. (UK) Chromosomal Abnormality Market Share (2011-2016)
Table Applied Spectral Imaging (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Applied Spectral Imaging (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure Applied Spectral Imaging (US) Chromosomal Abnormality Market Share (2011-2016)
Table SciGene Corporation (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SciGene Corporation (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure SciGene Corporation (US) Chromosomal Abnormality Market Share (2011-2016)
Table BI Biological Industries (Israel) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BI Biological Industries (Israel) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure BI Biological Industries (Israel) Chromosomal Abnormality Market Share (2011-2016)
Table ChromTrax (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ChromTrax (US) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure ChromTrax (US) Chromosomal Abnormality Market Share (2011-2016)
Table CytoTest, Inc. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CytoTest, Inc. (UK) Chromosomal Abnormality Production, Revenue, Price and Gross Margin (2011-2016)
Figure CytoTest, Inc. (UK) Chromosomal Abnormality Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chromosomal Abnormality
Figure Manufacturing Process Analysis of Chromosomal Abnormality
Figure Chromosomal Abnormality Industrial Chain Analysis
Table Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
Table Major Buyers of Chromosomal Abnormality
Table Distributors/Traders List
Figure Global Chromosomal Abnormality Production and Growth Rate Forecast (2016-2021)
Figure Global Chromosomal Abnormality Revenue and Growth Rate Forecast (2016-2021)
Table Global Chromosomal Abnormality Production Forecast by Regions (2016-2021)
Table Global Chromosomal Abnormality Consumption Forecast by Regions (2016-2021)
Table Global Chromosomal Abnormality Production Forecast by Type (2016-2021)
Table Global Chromosomal Abnormality Consumption Forecast by Application (2016-2021)